Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eurocine Vaccines AB (DE:8X4)
FRANKFURT:8X4
Eurocine Vaccines AB (8X4) Stock Price & Analysis
0 Followers
8X4 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.01 - €0.04
Previous Close€0.01
Volume0.00
Average Volume (3M)N/A
Market Cap
€491.25K
Enterprise Value-€854.14K
Total Cash (Recent Filing)kr15.51M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-4.40
Next Earnings
Aug 22, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding191,908,875
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
8X4 FAQ
What was Eurocine Vaccines AB’s price range in the past 12 months?
Eurocine Vaccines AB lowest stock price was €0.01 and its highest was €0.04 in the past 12 months.
What is Eurocine Vaccines AB’s market cap?
Currently, no data Available
When is Eurocine Vaccines AB’s upcoming earnings report date?
Eurocine Vaccines AB’s upcoming earnings report date is Aug 22, 2024 which is in 33 days.
How were Eurocine Vaccines AB’s earnings last quarter?
Currently, no data Available
Is Eurocine Vaccines AB overvalued?
According to Wall Street analysts Eurocine Vaccines AB’s price is currently Overvalued.
Does Eurocine Vaccines AB pay dividends?
Eurocine Vaccines AB does not currently pay dividends.
What is Eurocine Vaccines AB’s EPS estimate?
Eurocine Vaccines AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eurocine Vaccines AB have?
Currently, no data Available
What happened to Eurocine Vaccines AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eurocine Vaccines AB?
Currently, no hedge funds are holding shares in DE:8X4
---
Company Description
Eurocine Vaccines AB
Eurocine Vaccines AB focuses on the development and sale of nasal vaccines in Sweden. The company is developing nasal influenza vaccines, nasal vaccines for bird flu, nasal vaccines for pneumococcal disease such as pneumonia and meningitis. It offers vaccines for both children and adults.
---
---